J B CHEMICALS AND PHARMA (JBCHEPHARM)

NSE: ₹2,133.70
BSE: ₹2,131.65
Stock Performance
Corporate Announcements
2026-06-12 18:08:24
Letter To Shareholders - Integrated Annual Report 2025-26

Letter to shareholders - Integrated Annual Report 2025-26

2026-05-27 18:31:54
2026-05-26 20:34:57
Reg. 34 (1) Annual Report.

Annual Report for FY 26

2026-05-25 17:19:56
Intimation Of Notice Of AGM To Be Held On June 17, 2026

Intimation of Notice of AGM to be held on June 17, 2026

2026-05-25 17:05:53
Compliances-Reg.24(A)-Annual Secretarial Compliance

Disclosure of Annual Secretarial Compliance Certificate for the financial year ended March 31, 2026

2026-05-22 17:46:40
Intimation Of Record Date

Intimation of Record Date

2026-05-21 18:24:52
2026-05-20 18:48:18

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 852.58 836.76 800.10 809.20 952.31 955.76 913.51 901.34 1,039.90 1,022.65 990.91 836.43
YOY Revenue Growth % 19.05% 13.08% 9.76% 15.74% 11.7% 14.22% 14.17% 11.39% 9.2% 7% 8.47% -7.2%
Other Income 5.13 6.84 6.61 16.10 5.16 8.89 7.16 13.53 13.90 14.25 16.89 10.24
Total Income 857.71 843.60 806.71 825.30 957.47 964.65 920.67 914.87 1,053.80 1,036.90 1,007.80 846.67
Total Expenses + 659.61 642.88 630.30 662.19 723.26 730.45 711.14 715.70 788.84 768.41 766.62 691.39
Cost of Materials Consumed 218.75 221.36 198.77 177.16 251.67 179.22 200.18 188.97 240.83 225.36 212.03 233.80
Employee Benefit Expense 139.17 141.44 141.66 143.11 156.67 160.46 163.54 166.12 182.04 177.01 179.46 183.92
Other Expenses 189.16 178.99 183.06 193.57 199.57 203.27 202.34 200.79 233.71 222.24 231.16 205.23
Operating Profit 192.97 193.88 169.80 147.01 229.05 225.31 202.37 185.64 251.06 254.24 224.29 145.04
OPM % 22.6% 23.2% 21.2% 18.2% 24.1% 23.6% 22.2% 20.6% 24.1% 24.9% 22.6% 17.3%
Profit Before Tax + 198.10 200.72 176.41 163.11 234.21 234.20 209.53 199.17 264.96 268.49 241.18 128.10
Tax Expense 53.53 55.70 48.49 37.26 60.98 61.08 53.14 49.37 67.09 68.07 61.91 31.56
Tax % 27% 27.8% 27.5% 22.8% 26% 26.1% 25.4% 24.8% 25.3% 25.4% 25.7% 24.6%
Profit After Tax 144.57 145.02 127.92 125.85 173.23 173.12 156.39 149.80 197.87 200.42 179.27 96.54
EPS (Basic) 18.68 9.36 8.25 8.11 11.16 11.15 10.06 9.63 12.70 12.82 11.45 6.05

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 3,889.89 3,722.92 3,298.64 2,884.16 2,189.88 1,892.00 1,640.74
YOY Revenue Growth % 4.48% 12.86% 14.37% 31.7% 15.74% 15.31% -
Other Income 55.28 34.74 34.68 8.65 38.61 111.89 49.34
Total Income 3,945.17 3,757.66 3,333.32 2,892.81 2,228.49 2,003.88 1,690.09
Total Expenses + 3,015.26 2,880.55 2,594.98 2,365.77 1,757.20 1,410.18 1,155.47
Cost of Materials Consumed 912.02 820.04 816.04 783.78 601.87 542.17 452.10
Employee Benefit Expense 722.43 646.79 565.38 499.95 399.06 305.98 293.78
Other Expenses 892.34 805.97 744.77 682.79 538.21 403.89 409.59
Operating Profit 874.63 842.37 703.66 518.39 432.68 481.82 485.27
OPM % 22.5% 22.6% 21.3% 18% 19.8% 25.5% 29.6%
Profit Before Exceptional 929.91 877.11 738.34 527.04 471.29 593.71 349.56
Exceptional Items -27.18 0.00 0.00 0.00 0.00 0.00 -10.00
Profit Before Tax + 902.73 877.11 738.34 527.04 471.29 593.71 339.56
Tax Expense 228.63 224.57 194.98 138.15 110.29 146.62 71.42
Tax % 25.3% 25.6% 26.4% 26.2% 23.4% 24.7% 21%
Profit After Tax 674.10 652.54 543.36 388.89 361.00 447.08 268.14
EPS (Basic) 42.91 42.00 35.07 50.29 46.71 57.85 33.70

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 2,069.52 2,387.52 2,183.47 2,046.22 1,385.75 742.49 0.00
Property, Plant & Equipment 606.24 606.60 567.23 526.63 517.28 542.27 0.00
Capital Work in Progress 61.16 45.96 63.32 44.41 13.91 25.57 0.00
Non-Current Investments 168.91 170.86 166.58 146.75 145.69 145.88 0.00
Goodwill 4.32 4.32 4.32 4.32 4.32 4.32 0.00
Other Intangible Assets 1,185.89 1,272.37 1,353.87 1,290.71 682.06 18.01 0.00
Current Assets + 2,753.98 1,790.38 1,730.17 1,423.93 1,152.31 1,457.94 0.00
Inventories 643.38 471.64 461.20 386.95 349.78 278.91 0.00
Trade Receivables 711.71 768.09 624.78 523.58 518.05 374.11 0.00
Cash and Cash Equivalents 26.36 76.21 56.37 53.88 37.69 24.26 0.00
Current Investments 738.91 317.11 364.65 192.18 0.00 664.97 0.00
LIABILITIES & EQUITY
Total Equity 4,037.71 3,377.20 2,886.26 2,442.48 2,103.67 1,806.46 0.00
Equity Share Capital 16.06 15.57 15.52 15.48 15.46 15.46 0.00
Other Equity 4,021.65 3,361.63 2,870.74 2,427.00 2,088.21 1,791.00 0.00
Non-Current Liabilities 224.88 216.26 206.32 519.64 87.06 86.41 0.00
Current Liabilities 560.91 584.44 821.06 508.03 347.34 307.56 0.00
Total Liabilities 785.79 800.70 1,027.38 1,027.67 434.40 393.97 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 644.89 884.04 789.04 628.64 147.10 335.43 0.00
Cash from Investing Activities -587.22 -289.93 -412.45 -955.88 4.18 -230.68 0.00
Cash from Financing Activities -107.67 -574.26 -374.08 343.40 -137.85 -86.90 0.00
Net Increase/Decrease in Cash -49.85 19.84 2.49 16.19 13.42 17.86 0.00